Showing results (541-550 of 608) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 26, 2020
Environmental enrichment alleviates the deleterious effects of stress in experimental autoimmune encephalomyelitisAntoine Philippe Fournier, Erwan Baudron, Isabelle Wagnon, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2023
High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challengeChadi Azar, Grace Akiki, Sara F Haddad, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 28, 2022
Systemic inflammation and risk of multiple sclerosis - A presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 9, 2022
Continuous monitoring with wearables in multiple sclerosis reveals an association of cardiac autonomic dysfunction with disease severityMarc Hilty, Pietro Oldrati, Liliana Barrios, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 1, 2020
Mobile phone-based e-diary for assessment and enhancement of medications adherence among patients with multiple sclerosisDaniel Golan, Smadar Sagiv, Lea Glass-Marmor, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 21, 2020
CD8+ T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controlsI S Brorson, A M Eriksson, I S Leikfoss, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 28, 2021
The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Emily C Casady, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 5, 2026
T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3 + CD20+ cellsMasami Tanaka, Masako Kinoshita, Keiko TanakaMultiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Long-term worsening of different body functions in persons with progressive multiple sclerosisMarco Kaufmann, Claude Vaney, Laura Barin, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 11, 2022
Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensityClaudia Chien, Moritz Seiler, Fabian Eitel, et al.Pageof 61